Skip to main content
Erschienen in: Indian Journal of Gastroenterology 3/2017

23.06.2017 | Original Article

Prevalence and risk factors for low bone mineral density in ulcerative colitis

verfasst von: Ram Pratap Singh Bundela, Prachis Ashdhir, Kumar Shwetanshu Narayan, Mukesh Jain, Rupesh Kumar Pokharna, Sandeep Nijhawan

Erschienen in: Indian Journal of Gastroenterology | Ausgabe 3/2017

Einloggen, um Zugang zu erhalten

Abstract

Background

Inflammatory bowel disease (IBD) has been associated with increased risk of osteopenia and osteoporosis. Several risk factors contribute to this; however, studies evaluating their association have conflicting results.

Methods

We conducted a cross-sectional study with prospective enrollment of adult ulcerative colitis patients attending the Gastroenterology Department of Sawai Man Singh Hospital, Jaipur Rajasthan between June 2015 and December 2015. Demographic data including age, gender, body mass index (BMI), disease duration, type of disease, prior steroid use and vitamin D levels were recorded and compared with bone mineral density (BMD) using dual-energy X-ray absorptiometry (DEXA).

Results

Of the 55 patients enrolled, 41 (74.5%) had abnormal BMD; out of this, 19 (34.5%) had osteopenia and 22 (40.0%) had osteoporosis. In univariate analysis, disease duration and history of steroid use were observed as statistically significant. However, on multivariate analysis, only duration of disease was found to be a significant independent predictor of low BMD. Age, gender, BMI, low levels of vitamin D and steroid usage were not associated with low BMD.

Conclusion

Prevalence of low BMD is common in Indian ulcerative colitis patients. Prolonged disease duration appears to be the major risk factor.
Literatur
2.
Zurück zum Zitat Bernstein CN, Blanchard JF, Leslie W, Wajda A, Yu BN. The incidence of fracture among patients with inflammatory bowel disease. Ann Intern Med. 2000;133:795–9. Bernstein CN, Blanchard JF, Leslie W, Wajda A, Yu BN. The incidence of fracture among patients with inflammatory bowel disease. Ann Intern Med. 2000;133:795–9.
3.
Zurück zum Zitat Leichtmann GA, Bengoa JM, Bolt MJ, Sitrin MD. Intestinal absorption of calciferol and 25-hydroxycholecalciferol in patients with both Crohn’sdisease and intestinal resection. Am J Clin Nutr. 1991;54:548–52. Leichtmann GA, Bengoa JM, Bolt MJ, Sitrin MD. Intestinal absorption of calciferol and 25-hydroxycholecalciferol in patients with both Crohn’sdisease and intestinal resection. Am J Clin Nutr. 1991;54:548–52.
4.
Zurück zum Zitat Tilg H, Moschen AR, Kaser A, Pines A, Dotan I. Gut, inflammation and osteoporosis: basic and clinical concepts. Gut. 2008;57:684–94. Tilg H, Moschen AR, Kaser A, Pines A, Dotan I. Gut, inflammation and osteoporosis: basic and clinical concepts. Gut. 2008;57:684–94.
5.
6.
Zurück zum Zitat Jahnsen J, Falch JA, Mowinckel P, Aadland E. Vitamin D status, parathyroid hormone and bone mineral density in patients with inflammatory bowel disease. Scand J Gastroenterol. 2002;37:192–9. Jahnsen J, Falch JA, Mowinckel P, Aadland E. Vitamin D status, parathyroid hormone and bone mineral density in patients with inflammatory bowel disease. Scand J Gastroenterol. 2002;37:192–9.
7.
Zurück zum Zitat Bernstein CN, Bector S, Leslie WD. Lack of relationship of calcium and vitamin D intake to bone mineral density in premenopausal women with inflammatory bowel disease. Am J Gastroenterol. 2003;98:2468–73.CrossRefPubMed Bernstein CN, Bector S, Leslie WD. Lack of relationship of calcium and vitamin D intake to bone mineral density in premenopausal women with inflammatory bowel disease. Am J Gastroenterol. 2003;98:2468–73.CrossRefPubMed
8.
Zurück zum Zitat Khadgawat R, Makharia GK, Puri K. Evaluation of bone mineral density among patients with inflammatory bowel disease in a tertiary care setting in India. Indian J Gastroenterol. 2008;27:103–6.PubMed Khadgawat R, Makharia GK, Puri K. Evaluation of bone mineral density among patients with inflammatory bowel disease in a tertiary care setting in India. Indian J Gastroenterol. 2008;27:103–6.PubMed
9.
Zurück zum Zitat Abraham BP, Prasad P, Malaty HM. Vitamin D deficiency and corticosteroid use are risk factors for low bone mineral density in inflammatory bowel disease patients. Dig Dis Sci. 2014;59:1878–84.CrossRefPubMed Abraham BP, Prasad P, Malaty HM. Vitamin D deficiency and corticosteroid use are risk factors for low bone mineral density in inflammatory bowel disease patients. Dig Dis Sci. 2014;59:1878–84.CrossRefPubMed
10.
Zurück zum Zitat World Health Organization (1994) Assessment of fracture risk and its application to screening of post-menopausal osteoporosis. Technical Report Series 843. WHO, Geneva. World Health Organization (1994) Assessment of fracture risk and its application to screening of post-menopausal osteoporosis. Technical Report Series 843. WHO, Geneva.
11.
Zurück zum Zitat Pollak RD, Karmeli F, Eliakim R, Ackerman Z, Tabb K, Rachmilewitz D. Femoral neck osteopenia in patients with inflammatory bowel disease. Am J Gastroenterol. 1998;93:1483–90. Pollak RD, Karmeli F, Eliakim R, Ackerman Z, Tabb K, Rachmilewitz D. Femoral neck osteopenia in patients with inflammatory bowel disease. Am J Gastroenterol. 1998;93:1483–90.
12.
Zurück zum Zitat Del Carmen NM, Saavedra P, Jódar E, et al. Osteoporosis and metabolic syndrome according to socio-economic status; contribution of PTH, vitamin D and body weight: the Canarian Osteoporosis Poverty Study (COPS). Clin Endocrinol. 2013;78:681–6.CrossRef Del Carmen NM, Saavedra P, Jódar E, et al. Osteoporosis and metabolic syndrome according to socio-economic status; contribution of PTH, vitamin D and body weight: the Canarian Osteoporosis Poverty Study (COPS). Clin Endocrinol. 2013;78:681–6.CrossRef
13.
Zurück zum Zitat Jahnsen J, Falch JA, Aadland E, Mownickel P. Bone mineral density is reduced in patients with Crohn’s disease but not in patients with ulcerative colitis: a population based study. Gut. 1997;40:313–9.CrossRefPubMedPubMedCentral Jahnsen J, Falch JA, Aadland E, Mownickel P. Bone mineral density is reduced in patients with Crohn’s disease but not in patients with ulcerative colitis: a population based study. Gut. 1997;40:313–9.CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Hilmi I, Sunderesvaran K, Ananda V, Sarji SA, Arumugam K, Goh KL. Increased fracture risk and osteoporosis not associated with vitamin D levels in Malaysian patients with inflammatory bowel disease. J Clin Endocrinol Metab. 2013;98:2415–21. Hilmi I, Sunderesvaran K, Ananda V, Sarji SA, Arumugam K, Goh KL. Increased fracture risk and osteoporosis not associated with vitamin D levels in Malaysian patients with inflammatory bowel disease. J Clin Endocrinol Metab. 2013;98:2415–21.
15.
Zurück zum Zitat van Staa TP, Leufkens HG, Abenhaim L, Zhang B, Cooper C. Oral corticosteroids and fracture risk: relationship to daily and cumulative doses. Rheumatology (Oxford). 2000;39:1383–9. van Staa TP, Leufkens HG, Abenhaim L, Zhang B, Cooper C. Oral corticosteroids and fracture risk: relationship to daily and cumulative doses. Rheumatology (Oxford). 2000;39:1383–9.
16.
Zurück zum Zitat Tsironi E, Hadjidakis D, Mallas E, Tzathas C, Karamanolis DG, Ladas SD. Comparison of T- and Z-score in identifying risk factors of osteoporosis in inflammatory bowel disease patients. J Musculoskelet Neuronal Interact. 2008;8:79–84. Tsironi E, Hadjidakis D, Mallas E, Tzathas C, Karamanolis DG, Ladas SD. Comparison of T- and Z-score in identifying risk factors of osteoporosis in inflammatory bowel disease patients. J Musculoskelet Neuronal Interact. 2008;8:79–84.
Metadaten
Titel
Prevalence and risk factors for low bone mineral density in ulcerative colitis
verfasst von
Ram Pratap Singh Bundela
Prachis Ashdhir
Kumar Shwetanshu Narayan
Mukesh Jain
Rupesh Kumar Pokharna
Sandeep Nijhawan
Publikationsdatum
23.06.2017
Verlag
Springer India
Erschienen in
Indian Journal of Gastroenterology / Ausgabe 3/2017
Print ISSN: 0254-8860
Elektronische ISSN: 0975-0711
DOI
https://doi.org/10.1007/s12664-017-0758-0

Weitere Artikel der Ausgabe 3/2017

Indian Journal of Gastroenterology 3/2017 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.